AU3462797A - Regions nonessential for the proliferation of avipoxviruses, and recombinant avipoxviruses and vaccines prepared with the use of the same - Google Patents

Regions nonessential for the proliferation of avipoxviruses, and recombinant avipoxviruses and vaccines prepared with the use of the same

Info

Publication number
AU3462797A
AU3462797A AU34627/97A AU3462797A AU3462797A AU 3462797 A AU3462797 A AU 3462797A AU 34627/97 A AU34627/97 A AU 34627/97A AU 3462797 A AU3462797 A AU 3462797A AU 3462797 A AU3462797 A AU 3462797A
Authority
AU
Australia
Prior art keywords
avipoxviruses
nonessential
proliferation
regions
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU34627/97A
Inventor
Takashi Okuda
Takanori Sato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zeon Corp
Original Assignee
Nippon Zeon Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Zeon Co Ltd filed Critical Nippon Zeon Co Ltd
Publication of AU3462797A publication Critical patent/AU3462797A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
AU34627/97A 1996-07-18 1997-07-18 Regions nonessential for the proliferation of avipoxviruses, and recombinant avipoxviruses and vaccines prepared with the use of the same Abandoned AU3462797A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP8-207797 1996-07-18
JP8207797A JPH1028586A (en) 1996-07-18 1996-07-18 Non-essential region of avipoxvirus, recombinant avipoxvirus and vaccine using this region
PCT/JP1997/002508 WO1998003635A1 (en) 1996-07-18 1997-07-18 Regions nonessential for the proliferation of avipoxviruses, and recombinant avipoxviruses and vaccines prepared with the use of the same

Publications (1)

Publication Number Publication Date
AU3462797A true AU3462797A (en) 1998-02-10

Family

ID=16545659

Family Applications (1)

Application Number Title Priority Date Filing Date
AU34627/97A Abandoned AU3462797A (en) 1996-07-18 1997-07-18 Regions nonessential for the proliferation of avipoxviruses, and recombinant avipoxviruses and vaccines prepared with the use of the same

Country Status (3)

Country Link
JP (1) JPH1028586A (en)
AU (1) AU3462797A (en)
WO (1) WO1998003635A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102426258B (en) * 2011-11-11 2014-03-05 中国兽医药品监察所 Positive serum national standard substance used for newcastle disease hemagglutination inhibition test and preparation method thereof
EP2644702A1 (en) * 2012-03-30 2013-10-02 Ceva Sante Animale Multivalent recombinant avian herpes virus and vaccine for immunizing avian species

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1322731C (en) * 1986-09-22 1993-10-05 Hisatoshi Shida Gene for a-type inclusion body of poxvirus
AU605567B2 (en) * 1987-03-11 1991-01-17 Nippon Zeon Co., Ltd. Recombinant avipoxvirus
JPH05244940A (en) * 1991-08-09 1993-09-24 Nippon Zeon Co Ltd Recombinant avipox virus and vaccine composed thereof
JPH0544269A (en) * 1991-08-14 1993-02-23 Dow Kakoh Kk Insert for thermal insulation slab
JPH0630784A (en) * 1992-07-13 1994-02-08 Shionogi & Co Ltd Production of avian virus antigen protein

Also Published As

Publication number Publication date
WO1998003635A1 (en) 1998-01-29
JPH1028586A (en) 1998-02-03

Similar Documents

Publication Publication Date Title
HUP9802217A3 (en) Recombinant mva virus, and the use thereof
AU4894197A (en) Syringe, injector and injector system
AU7264694A (en) Defective adenovirus vectors and use thereof in gene therapy
HK1054104A1 (en) System for controlling the distribution and use ofcomposite digital works.
AU3008297A (en) Dihydropyrimidines and uses thereof
AU2639095A (en) Recombinant hk2 polypeptide
AU1910495A (en) Efficient digital signature algorithm and use thereof
AU4397597A (en) Novel phytase and process for the preparation thereof
AU3119895A (en) Recombinant virus vectors
AU3882997A (en) Human telomerase gene
AU5219498A (en) Wireless access system with did and aiod functions
AU3480297A (en) Modified mcm-56, its preparation and use
AU3431297A (en) Two-step immunization procedure against the pyramyxoviridae family of viruses using recombinant virus and subunit protein preparation
AU1927797A (en) Vectors based on recombinant defective viral genomes, and their use in the formulation of vaccines
AU3916097A (en) Communication system with zero handover mute
AU5355996A (en) Human chemokine polypeptides
AU3432397A (en) An alkylation catalyst and the application thereof
AU6299594A (en) Recombinant fowlpox virus s-fpv-043 and uses thereof
AU1769497A (en) Modified cytokines for therapeutic use
AU4373197A (en) Recombinant single chain antibodies directed against the gp54 cancer marker, composition comprising same and use thereof
AU1952497A (en) Novel antibody-cytokine fusion protein, and methods of making and using the same
AU2408397A (en) Ob protein receptor genes and use of the same
AU5378498A (en) Adipocyte-specific differentiation-related protein
AU3462797A (en) Regions nonessential for the proliferation of avipoxviruses, and recombinant avipoxviruses and vaccines prepared with the use of the same
AU5125298A (en) Bicistronic recombinant viruses useful for the treatment of dyslipoproteinemia-related pathologies